EMD-25108

Single-particle
3.67 Å
EMD-25108
3D View Gallery
Deposition: 05/10/2021
Map released: 12/10/2022
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25108

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7sge summary report (pdf.gz) Map-7sge FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

I53-50 nanoparticle core reconstructed from GPC-I53-50NP by focused refinement

EMD-25108

Single-particle
3.67 Å
EMD-25108
3D View Gallery
Deposition: 05/10/2021
Map released: 12/10/2022
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: synthetic construct
Sample: I53-50 nanoparticle core recovered from GPC-I53-50 nanoparticle
Fitted models: 7sge

Deposition Authors: Antanasijevic A, Brouwer PJM
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection.
Brouwer PJM, Antanasijevic A, Ronk AJ , Muller-Krauter H , Watanabe Y, Claireaux M, Perrett HR , Bijl TPL, Grobben M , Umotoy JC, Schriek AI, Burger JA, Tejjani K, Lloyd NM, Steijaert TH, van Haaren MM, Sliepen K, de Taeye SW, van Gils MJ, Crispin M , Strecker T , Bukreyev A, Ward AB, Sanders RW
(2022) Cell Host Microbe , 30 , 1759
PUBMED: 36400021
DOI: doi:10.1016/j.chom.2022.10.018
ISSN: 1934-6069
Grant Support: